agilon health, inc. AGL
96.23 USD +8.44 (+9.61%)
At closeNov 5, 2026, 4:10 AM EST
56.00 -40.23 -41.80%
Pre-market · Nov 5, 4:10 AM ET
90.23 Day range 98.02
7.48 52-week range 133.04
- YTD
- +458.50%
- 1 year
- +410.50%
- Market cap
- 1.62B
- Revenue (ttm)
- 5.92B
- Profit margin
- -3.92%
- EPS (ttm)
- -15.41
- Shares out
- 16.79M
- Forward P/E
- 40.39
- YTD return
- +458.50%
- 1-year return
- +410.50%
- Volume
- 282.32K
- Avg volume
- 251.39K
- Open
- 91.17
- Previous close
- 87.79
- Day's range
- 90.23 – 98.02
- 52-week range
- 7.48 – 133.04
- Beta
- 3.11
- Analysts
- Buy
- Price target
- 115.83 (+20.4%)
- Earnings date
- Feb 24, 2027
YTD +78.80 (+467.66%)
Key statistics
- Enterprise value
- 1.32B
- PEG ratio
- 0.00
- Price / sales
- 0.27
- Price / book
- 7.04
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 7.20%
- Free cash flow
- -145.68M
- Total cash
- 185.63M
- Total debt
- 33.45M
- Return on equity
- -78.94%
- Short % of float
- 8.54%
- 50-day average
- 87.55
- 200-day average
- 65.61
Analyst view
Consensus: buy
Buy
Price target (mean) 115.83 +20.4% upside
Now 96.23
- Target (low)
- 85.00
- Target (mean)
- 115.83
- Target (high)
- 146.00
Ratings (0m) 15 5 buy · 9 hold · 1 sell
- Strong buy0
- Buy5
- Hold9
- Sell0
- Strong sell1
Next earnings
Feb 24, 2027
Expected Feb 24, 2027. Consensus EPS estimate -0.73.
Financials — quick view
AGL Revenue — quarterly 1.52B
AGL Net income — quarterly 34.91M
AGL EPS — quarterly 2.08
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 24, 2027 | Dec 30, 2026 | -3.47 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | -1.23 | 1.97 | +3.20 | +260.16% |
| Aug 5, 2026 | Jun 30, 2026 | 0.144 | 1.04 | +0.90 | +622.22% |
| May 6, 2026 | Mar 31, 2026 | 1.13 | 1.80 | +0.67 | +59.29% |
| Feb 25, 2026 | Dec 31, 2025 | -6.75 | -11.50 | -4.75 | -70.37% |
| Nov 4, 2025 | Sep 30, 2025 | -3.73 | -6.75 | -3.02 | -80.73% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 15, 2026 | Bernstein | up | Market Perform | Outperform |
| Aug 24, 2026 | JP Morgan | main | Underweight | Underweight |
| Aug 11, 2026 | Wells Fargo | main | Overweight | Overweight |
| Aug 11, 2026 | Citigroup | up | Sell | Neutral |
| Aug 6, 2026 | Truist Securities | main | Hold | Hold |
| Aug 6, 2026 | Benchmark | main | Buy | Buy |
About agilon health, inc.
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- agilonhealth.com
News
Agilon Health Q3 Earnings Call Highlights 
Compared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key Metrics 
Agilon Health (AGL) Q3 Earnings and Revenues Surpass Estimates 
agilon health, inc. (AGL) Q3 2026 Earnings Call Transcript 
Agilon Health Q3 2026 Earnings Call Transcript 
Agilon Health Raises FY2026 Sales Guidance from $5.775B-$5.860B to $5.870B-$5.890B vs $5.827B Est 
Agilon Health Q3 EPS $1.97 Beats $(1.46) Estimate, Sales $1.519B Beat $1.461B Estimate
Your note
Sign in to keep a note on AGL — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GERTSCH TIMOTHY | Officer | Stock Award(Grant) | Mar 31, 2026 | 14,324 |
| MANSUKANI SHARAD S. | Director | Stock Award(Grant) | Jun 1, 2026 | 56,242 |
| O'ROURKE TIMOTHY PATRICK | Chief Executive Officer | Stock Award(Grant) | May 6, 2026 | 320,000 |
| SCHWANEKE JEFFREY A | Chief Financial Officer | Stock Award(Grant) | Mar 31, 2026 | 141,234 |
| SELL STEVEN J | Chief Executive Officer | Stock Award(Grant) | Mar 31, 2025 | 974,371 |
| SHAKER BENJAMIN | Officer | Stock Award(Grant) | Mar 31, 2026 | 123,525 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 23.82% | 4,000,000 | 381.52M | Jun 29, 2026 |
| Morgan Stanley | 11.98% | 2,011,196 | 191.83M | Jun 29, 2026 |
| North Peak Capital Management, Llc | 8.84% | 1,485,066 | 141.65M | Jun 29, 2026 |
| Blackrock Inc. | 6.83% | 1,146,520 | 109.36M | Jun 29, 2026 |
| AQR Capital Management, LLC | 4.12% | 692,541 | 66.05M | Jun 29, 2026 |
| Goldman Sachs Group Inc | 4.09% | 686,792 | 65.51M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.20% | 369,638 | 35.26M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.93% | 323,520 | 30.86M | Sep 29, 2026 |
| Morgan Stanley Insight Fund | 1.64% | 274,566 | 26.19M | Jun 29, 2026 |
| Brighthouse Funds Trust I-Morgan Stanley Discovery Portfolio | 1.47% | 246,726 | 23.53M | Jun 29, 2026 |
| MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfolio | 1.43% | 239,593 | 22.85M | Jun 29, 2026 |
| SCHWAB STRATEGIC TRUST-Schwab Fundamental U.S. Small Company ETF | 1.15% | 193,118 | 18.42M | Aug 30, 2026 |